Study of Lenalidomide to Evaluate Safety and Efficacy in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia

Update Il y a 6 ans
Reference: NCT00963105

Woman and Man

Extract

The purpose of this study is to determine the safety and effectiveness of different dose regimen of lenalidomide in patients with relapsed or refractory chronic lymphocytic leukemia.


Inclusion criteria

  • Relapsed or Refractory Chronic Lymphocytic Leukemia


Links